Northwestern Mutual Wealth Management CO Bei Gene, Ltd. Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 20 shares of BGNE stock, worth $4,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 46
56.52%
Holding current value
$4,120
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding BGNE
# of Institutions
252Shares Held
45.3MCall Options Held
292KPut Options Held
119K-
Baker Bros. Advisors LP New York, NY10.6MShares$2.18 Billion25.41% of portfolio
-
Capital International Investors Los Angeles, CA6.43MShares$1.32 Billion0.29% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.18MShares$1.07 Billion26.65% of portfolio
-
Primecap Management CO Pasadena, CA4.97MShares$1.02 Billion0.84% of portfolio
-
Baillie Gifford & CO3.71MShares$763 Million0.64% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $21.4B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...